LobbyingPrimerica Life Insurance Company lobbying by quarter
Primerica Life Insurance Company's latest lobbying report covers Q2 2026, at $390K. The four quarters Q4 2025–Q3 2026 total $1.5M. Its first report covers Q4 2022; the issues it reports most are Consumer Issues/Safety/Protection and Labor Issues/Antitrust/Workplace.
Primerica Life Insurance Company
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.5M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $480K | 1 |
| Q1 2023 | $630K | 1 |
| Q2 2023 | $450K | 1 |
| Q3 2023 | $370K | 1 |
| Q4 2023 | $440K | 1 |
| Q1 2024 | $670K | 1 |
| Q2 2024 | $400K | 1 |
| Q3 2024 | $370K | 1 |
| Q4 2024 | $380K | 1 |
| Q1 2025 | $730K | 1 |
| Q2 2025 | $460K | 1 |
| Q3 2025 | $350K | 1 |
| Q4 2025 | $390K | 1 |
| Q1 2026 | $740K | 1 |
| Q2 2026 | $390K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Consumer protection and safety$1.5M · 15 reports
- Labor, antitrust and workplace$1.5M · 15 reports
- Financial institutions and securities$1.4M · 14 reports
- Retirement$1.1M · 11 reports
- Taxation$1M · 11 reports
- Housing$331.7K · 4 reports
- Medicare and Medicaid$240K · 3 reports
- Health issues$73.3K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES13 reports
- SENATE12 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-housePrimerica Life Insurance Company | $7.3M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| GREG W THOMAS | LD-Rep. Mick Mulvaney & DepCoS/LD - Rep. Gresham Barrett | Q2 2026 |
| HADLEA BENDER | Intern-Rep. John Carter | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/18for Q2 | In-house | $390K |
| 04/20for Q1 | In-house | $740K |
| 01/20for Q4 2025 | In-house | $390K |
| 01/09for Q3 2024 | In-house | $370K |
| 25/10/20for Q3 2025 | In-house | $350K |
| 25/07/25for Q1 2025 | In-house | $730K |
| 25/07/21for Q2 2025 | In-house | $460K |
| 25/04/18for Q1 2025 | In-house | $790K |
| 25/01/17for Q4 2024 | In-house | $380K |
| 24/10/21for Q3 2024 | In-house | $380K |
| 24/07/22for Q2 2024 | In-house | $400K |
| 24/04/22for Q1 2024 | In-house | $670K |
| 24/01/19for Q4 2023 | In-house | $440K |
| 23/10/20for Q3 2023 | In-house | $370K |
| 23/07/19for Q2 2023 | In-house | $450K |
| 23/04/20for Q1 2023 | In-house | $630K |
| 23/01/20for Q4 2022 | In-house | $480K |